Skip to main content
. 2019 Aug 30;9(8):e029861. doi: 10.1136/bmjopen-2019-029861

Table 6.

Prevalence of cardiovascular risk factors, metabolic syndrome, comorbidities and cancer according to lower and higher inflammation

Variables n Lower inflammation
(plasma CRP <0.54 mg/L)
Higher inflammation
(plasma CRP ≥0.54 mg/L)
P value
Stroke 121 41 (1.31) 80 (2.03) 0.037
Myocardial infarction or angina 68 (1.99) 97 (2.40) 0.332
Hypercholesterolaemia 1209 540 (16.58) 699 (21.57) <0.001
Hypertriglyceridaemia 677 194 (9.83) 483 (22.15) <0.001
Diabetes 744 243 (7.36) 501 (14.06) <0.001
Impaired fasting glucose 1385 504 (17.48) 881 (28.85) <0.001
Hypertension 1909 681 (20.87) 1228 (34.85) <0.001
Prehypertension 1409 640 (24.32) 769 (26.96) <0.001
Metabolic syndrome 2193 684 (21.81) 1509 (44.60) <0.001
Osteoarthritis 639 250 (6.83) 389 (10.11) <0.001
Rheumatoid arthritis 125 59 (1.76) 66 (1.68) 0.793
Osteoporosis 485 186 (4.76) 299 (7.35) <0.001
Pulmonary tuberculosis 223 81 (2.91) 142 (4.31) 0.014
Asthma 157 64 (2.48) 93 (2.84) 0.483
Thyroid disease 223 114 (3.33) 109 (3.29) 0.007
Atopic dermatitis 152 81 (4.03) 71 (2.83) 0.053
Allergic rhinitis 784 390 (16.25) 391 (14.42) 0.117
Gastric cancer 42 20 (0.48) 22 (0.56) 0.654
Colon cancer 23 8 (0.17) 15 (0.31) 0.252
Breast cancer 30 15 (0.47) 15 (0.38) 0.608
Cervical cancer 38 20 (0.70) 18 (0.45) 0.215
Lung cancer 11 4 (0.10) 7 (0.19) 0.268
Thyroid cancer 59 27 (0.96) 32 (0.92) 0.906

Values are presented as unweighted n (weighted %).

CRP, C reactive protein.